Skip to contentHALVORSEN OLE ANDREAS — Urovant Sciences Ltd. insider: 60 transactions · InsiderLensHALVORSEN OLE ANDREAS
- 10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
- 10% owner at LABRANCHE & CO INC · on record since Mar 20, 2024
- 10% owner at APi Group Corp · on record since Mar 7, 2024
- 10% owner at TASER INTERNATIONAL INC · on record since Jul 13, 2016
- 10% owner at Arbutus Biopharma Corp · on record since Jul 13, 2016
- 10% owner at Glori Energy Inc. · on record since Jun 7, 2024
- 10% owner at TIC Solutions, Inc. · on record since Feb 14, 2025
- 10% owner at Myovant Sciences Ltd. · on record since Oct 26, 2016
- 10% owner at Wayfair Inc. · on record since Nov 24, 2014
- 10% owner at FIRST DATA CORP · on record since Oct 15, 2015
- Former 10% Owner at Editas Medicine, Inc. · on record since Feb 9, 2016
- 10% owner at Editas Medicine, Inc. · on record since Feb 8, 2016
- 10% owner at FIGS, Inc. · on record since Jun 7, 2021
- 10% owner at GENENTECH INC · on record since Sep 23, 2021
- 10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
- 10% owner at BridgeBio Pharma, Inc. · on record since Jun 28, 2019
- 10% owner at ADAPTEC INC · on record since Jun 26, 2019
- Former 10% Owner at Urovant Sciences Ltd. · on record since Jul 12, 2019
- Former 10% Owner at Arbutus Biopharma Corp · on record since Jul 12, 2019
- Former 10% Owner at TASER INTERNATIONAL INC · on record since Jul 12, 2019
- Former 10% Owner at Myovant Sciences Ltd. · on record since Jul 12, 2019
- 10% owner at ADVANCED PHOTONIX INC · on record since Apr 28, 2020
- 10% owner at Zentalis Pharmaceuticals, Inc. · on record since Apr 8, 2020
- 10% owner at Inhibrx Biosciences, Inc. · on record since Aug 28, 2020
- 10% owner at Rallybio Corp · on record since Jul 29, 2021
- 10% owner at 4D Molecular Therapeutics, Inc. · on record since Dec 17, 2020
- 10% owner at PROCEPT BioRobotics Corp · on record since Sep 21, 2021
- 10% owner at Roivant Sciences Ltd. · on record since Oct 1, 2021
- 10% owner at Amylyx Pharmaceuticals, Inc. · on record since Jan 13, 2022
- 10% owner at Frazier Lifesciences Acquisition Corp · on record since Nov 25, 2022
Insider trading activity of HALVORSEN OLE ANDREAS
- Transactions on record
- 60
- since Oct 8, 2014
- Open-market buys
- 27
- $67M
- Open-market sells
- 3
- $302M
- Companies traded
- 10
- last filing Jul 1, 2025
Figures computed from official regulatory filings — methodology.
Companies where HALVORSEN OLE ANDREAS has traded
- BridgeBio Pharma, Inc.1 tx · $154M · Jul 1, 2025
- ADVANCED PHOTONIX INC2 tx · $200M · Jan 5, 2022
- PROCEPT BioRobotics Corp7 tx · $14M · Sep 21, 2021
- Zentalis Pharmaceuticals, Inc.1 tx · $25.3M · Dec 3, 2020
- ADAPTEC INC10 tx · $127.7M · Jan 30, 2020
- Urovant Sciences Ltd.11 tx · $38M · Jun 19, 2019
- TASER INTERNATIONAL INC1 tx · $10M · Dec 20, 2018
- FIRST DATA CORP10 tx · Apr 15, 2016
- Editas Medicine, Inc.11 tx · Feb 9, 2016
Track record of HALVORSEN OLE ANDREAS
Statistical track record
Free- Open-market buys
- 29
- Last buy
- Jan 3, 2022
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of HALVORSEN OLE ANDREAS
Co-insiders of HALVORSEN OLE ANDREAS
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
6 tx · $60.4K · Nov 5, 2014
4D Molecular Therapeutics, Inc. +13
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 1, 2025 | Sell | -3,500,000 | 44.00 USD | $154M | SEC |
| Jan 5, 2022 | BuyD | 4,000 | 1,000.00 USD | $4M | SEC |
| Jan 5, 2022 | BuyD | 196,000 | 1,000.00 USD | $196M | SEC |
| Sep 21, 2021 | Other | 113,737 | — | — | SEC |
| Sep 21, 2021 | OtherD | -3,407,028 | 0.00 USD | $0 | SEC |
| Sep 21, 2021 | OtherD | -113,737 | 0.00 USD | $0 | SEC |
| Sep 21, 2021 | OtherD | -678,985 | 0.00 USD | $0 | SEC |
| Sep 21, 2021 | Buy | 400,000 | 35.00 USD | $14M | SEC |
| Sep 21, 2021 | Other | 678,985 | — | — | SEC |
| Sep 21, 2021 | Other | 3,407,028 | — | — | SEC |
| Dec 3, 2020 | Sell | -500,000 | 50.50 USD | $25.3M | SEC |
| Jan 30, 2020 | Sell | -4,912,899 | 24.98 USD | $122.7M | SEC |
| Jul 2, 2019 | OtherD | -290,572 | — | — | SEC |
| Jul 2, 2019 | OtherD | -15,524,350 | — | — | SEC |
| Jul 2, 2019 | Other | 2,007,740 | — | — | SEC |
| Jul 2, 2019 | Other | 18,908,945 | — | — | SEC |
| Jul 2, 2019 | Other | 15,524,350 | — | — | SEC |
| Jul 2, 2019 | OtherD | -2,007,740 | — | — | SEC |
| Jul 2, 2019 | Buy | 250,000 | 20.00 USD | $5M | SEC |
| Jul 2, 2019 | OtherD | -18,908,945 | — | — | SEC |
| Jul 2, 2019 | Other | 290,572 | — | — | SEC |
| Jun 19, 2019 | Buy | 6,541 | 8.53 USD | $55.8K | SEC |
| Jun 19, 2019 | Buy | 4,957 | 8.17 USD | $40.5K | SEC |
| Jun 19, 2019 | Buy | 6,706 | 8.21 USD | $55.1K | SEC |
| May 23, 2019 | Buy | 4,802 | 7.76 USD | $37.3K | SEC |